Cellular Therapy and Transplant Section News

Your child will be cared for by one of the most accomplished teams of cellular therapy and transplant experts in the world. Our team includes doctors, nurses, social workers, nutritionists, psychologists and more.

How we serve you

Existing patients or family members

215-590-3025

New patients, referrals and second opinions

267-426-0762

Dr. John Maris Receives QED Award to Develop Novel Treatment for Neuroblastoma

Feb 7, 2019

A CHOP research leader received an award from the University City Science Center to help develop a new T-cell based treatment for a childhood cancer.

Humanized CD19: CAR-T Immunotherapy for First Relapse of ALL in Down Syndrome Patient

Jan 11, 2019

An alternative, humanized CD19 CAR T product for first relapse of pediatric ALL is being evaluated in a clinical trial at Children's Hospital of Philadelphia.

Photograph of an acute lymphoblastic leukemia cell

CHOP Scientists Report How Some Cancer Cells Develop Resistance to CAR T-cell Therapy

Nov 27, 2018

CHOP researchers analyze how some cancer cells resist a groundbreaking cellular therapy, and have found clues to overcoming that resistance.

CHOP Opens Manufacturing Facility, Making Tools for Disease Cures

Nov 1, 2018

The grand opening of CHOP’s new Clinical Manufacturing Facility highlights its role in manufacturing tools for 21st century precision medicine, to bring innovative treatments to patients.

Immunotherapy: What’s Next for CAR-T Therapy

Jan 24, 2019

Trials of more game-changing cell therapies for pediatric cancer and other diseases are underway or on the horizon at Children's Hospital of Philadelphia.

Advancing the Field of Cell Therapy

Sep 3, 2018

A bone marrow transplant saved Kaleo’s life. Today, he’s a dancing machine. His success story is an example of CHOP’s expertise in the field of cellular therapy.

Parents Magazine Names Children’s Hospital of Philadelphia Among 20 Most Innovative Children’s Hospitals

Sep 5, 2018

Children’s Hospital of Philadelphia was recognized specifically for significant contributions to the development of a new treatment for a certain pediatric leukemia.

Paulina walking outside with her parents

European Commission Approves Innovative CAR T-cell Therapy Pioneered at Children’s Hospital of Philadelphia

Aug 24, 2018

The European Commission (EC) approves Kymriah, the first-ever U.S. FDA approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers.

Dr. Stephan Grupp to Lead Cellular Therapy and Transplant Section in CHOP Cancer Program

May 15, 2017

A leading pediatric oncologist at CHOP, Dr. Grupp is now Chief of the Section of Cellular Therapy and Transplant in the Hospital’s Division of Oncology.

CHOP’s Breakthrough Cancer Immunotherapy Program Receives Generous Grant from the Emily Whitehead Foundation

Apr 17, 2018

Emily Whitehead, the first pediatric patient to receive CAR T-cell therapy, and her family honor the CHOP team who saved her life with a $250,000 research grant to expand the use of the therapy for relapsed or refractory ALL.

Find a research study

Innovation and your child

Find research studies